Focused Wealth Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-188
Closed -$2.74K 1136
2023
Q1
$2.74K Hold
188
﹤0.01% 763
2022
Q4
$1.37K Hold
188
﹤0.01% 823
2022
Q3
$1K Hold
188
﹤0.01% 930
2022
Q2
$1K Hold
188
﹤0.01% 903
2022
Q1
$2K Buy
+188
New +$1.7K ﹤0.01% 836

Focused Wealth Management's AMYT Position: Q2 2023 in Review

Focused Wealth Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 188 shares — an estimated $2.74K sold.

Focused Wealth Management first reported a position in AMYT in Q1 2022 and held it in 5 quarters. The position peaked at $2.74K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Focused Wealth Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Focused Wealth Management sold 188 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $2.74K.
  • Focused Wealth Management first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
  • Focused Wealth Management's Amryt Pharma plc American Depositary Shares position peaked at $2.74K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Focused Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.